Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 3
2009 5
2010 8
2011 8
2012 5
2013 7
2014 14
2015 18
2016 20
2017 30
2018 20
2019 32
2020 24
Text availability
Article attribute
Article type
Publication date

Search Results

167 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean tingling Ma (222 results)?
Targeting the circBMPR2/miR-553/USP4 Axis as a Potent Therapeutic Approach for Breast Cancer.
Liang Y, Song X, Li Y, Ma T, Su P, Guo R, Chen B, Zhang H, Sang Y, Liu Y, Duan Y, Zhang N, Li X, Zhao W, Wang L, Yang Q. Liang Y, et al. Among authors: Ma T. Mol Ther Nucleic Acids. 2019 Sep 6;17:347-361. doi: 10.1016/j.omtn.2019.05.005. Epub 2019 May 22. Mol Ther Nucleic Acids. 2019. PMID: 31302495 Free PMC article.
circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer.
Liang Y, Song X, Li Y, Su P, Han D, Ma T, Guo R, Chen B, Zhao W, Sang Y, Zhang N, Li X, Zhang H, Liu Y, Duan Y, Wang L, Yang Q. Liang Y, et al. Among authors: Ma T. Oncogene. 2019 Oct;38(42):6850-6866. doi: 10.1038/s41388-019-0926-z. Epub 2019 Aug 12. Oncogene. 2019. PMID: 31406252
167 results
Jump to page
Feedback